Le Centre Hospitalier Universitaire de Martinique est un Centre Hospitalier Universitaire d'une capacité totale de 1506 lits en 2017. Situé à Fort de France, sur l'ile de la Martinique

During the past decade, CHU de Martinique conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.2% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 2 clinical trials were completed. i.e. 5.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Martinique" #1 sponsor was "University Hospital Center of Martinique" with 46 trials, followed by "ANRS, Emerging Infectious Diseases" with 4 trials sponsored, "Centre Hospitalier Universitaire de Nīmes" with 2 trials sponsored, "DatAids" with 2 trials sponsored and "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Martinique" #1 collaborator was "Clinique Antilles-Guyane" with 3 trials as a collaborator, "Centre Hospitalier de Cayenne" with 2 trials as a collaborator, "French National Network of Clinical Research in Infectious Diseases (RENARCI)" with 2 trials as a collaborator, "GIRCI SOHO" with 2 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Martinique" are "Cardiac Amyloidosis" (3 trials), "HIV Infections" (3 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials) and "Chikungunya Virus Infection" (2 trials). Many other conditions were trialed in "CHU de Martinique" in a lesser frequency.

Most popular intervention types in "CHU de Martinique" are "Other" (22 trials), "Drug" (11 trials), "Biological" (7 trials), "Procedure" (7 trials) and "Diagnostic Test" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Temocillin" (2 trials), ""Antillanisée" Mini Mental State Examination (MMSEa)" (1 trials), "3 days of antibiotherapy" (1 trials) and "APSOM vs Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Martinique" are 63 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Martinique". 8 are not yet recruiting, 20 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in CHU de Martinique, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Martinique, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 21 trials that are defined as “Not Applicable".